← All Sponsors
SPONSOR

Calluna Pharma AS

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Idiopathic Pulmonary Fibrosis
NCT06736990 Phase 2
Recruiting

A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis
United States, Denmark, France View Trial →